Altria Group Inc. (MO) Stock Analysis - Price Target, Strong Buy Rating & DCF Valuation (2026)

MO — trading at ~15x P/E with a 5.8% dividend yield, smoke-free pivot in oral nicotine pouches offsetting cigarette volume decline, amid litigation and FDA/ITC regulatory risk.

MO Price Target & Rating

MO's quantitative grade is Strong Buy, with moderate downside risk (CVaR -13.6%), and quality metrics (net margin 40%). Altria Group Inc. (MO) trades at $71.59 with a valuation grade of Strong Buy: a trailing P/E of 14.9x at a 38% discount to sector median, net margins of 39.5%, a DCF-implied intrinsic range of $75–$111 suggesting a +29% margin of safety, beta 0.49 (defensive risk profile).

VALUEFAIR RANGEPREMIUM BEAR$74.73BULL$110.52 BASE$92 CURRENT$72 MOS vs BASE+27.8% DCF VALUATION RANGE · MO
  • Valuation: Strong Buy grade — P/E 14.9x — DCF range $75–$111 implies +29% margin of safety
  • Risk: CVaR -13.6% (95th percentile, 1-month) indicates moderate tail exposure; beta of 0.49 amplifies broad market moves in both directions
  • Strengths: Size 4.0/5, 40% net margin dominate the factor profile
  • Catalyst: Q2 2026 earnings on July 30, 2026 — first full quarter reported by new CEO Sal Mancuso, testing whether the $5.56-$5.72 EPS guidance range holds and whether oral/nicotine pouch share stabilizes.
  • Bear catalyst: Domestic cigarette shipment declines accelerate into the low-double-digits or worse, the dividend payout ratio pushes further above 100% forcing a freeze or cut, or an adverse litigation ruling/new FDA menthol-flavor ban materially impairs volumes or cash flow.
MO — Quantitative Snapshot July 2026
RatingStrong Buy
Price$71.59
Why Strong BuyAttractive valuation relative to peers with solid fundamentals
Tail riskCVaR -13.6% over one month at the 95th percentile
DCF range$75–$111 intrinsic range; margin of safety +29%
Best useCore large-cap Consumer Defensive holding — not a source of diversified sector exposure
Next watchEarnings delivery consistency and margin trajectory
MO Quantitative Factor Radar Chart Pentagon radar chart showing MO factor scores: Value 4.5, Quality 3.0, Momentum 3.0, Volatility 5.0, Size 4.0 — each scored on a 1 to 5 scale. VALUE 4.5 QUALITY 3.0 MOMENTUM 3.0 VOLATILITY 5.0 SIZE 4.0
Value
4.5 / 5
Quality
3.0 / 5
Momentum
3.0 / 5
Volatility
5.0 / 5
Size
4.0 / 5
MO Key Metrics — Altria Group Inc. 2026
MetricValue
Current Price$71.59
P/E Ratio (TTM)14.9x
Forward P/E12.2x
PEG Ratio11.46x
P/S Ratio5.9
EV/EBITDA9.0
Beta0.49
Net Margin39.5%
Dividend Yield5.82%
CVaR (95%, 1M)-13.6%
Market Cap$119.5B
Historical Simulation · Daily Log Returns
MO — Daily Return Distribution
Altria Group Inc.  ·  250 trading days  ·  CVaR illustrated on real data
Jul 2025 – Jul 2026 Daily log returns
Confidence level 95%
-1.89%
VaR · 95%
Max-loss threshold
-3.31%
CVaR · 95%
Avg loss in tail
12
Days in tail
of 250 sessions
250
Daily returns
Jul 2025 – Jul 2026
ℹ️
Risk Framework · A.L. Capital Advisory
CVaR & Tail-Risk Methodology
Why variance understates downside risk in non-normal distributions — and how CVaR corrects that blind spot
Analyst View
Anton Ladnyi, CFA · A.L. Capital Advisory Updated 2026-07-09

MO — trading at ~15x P/E with a 5.8% dividend yield, smoke-free pivot in oral nicotine pouches offsetting cigarette volume decline, amid litigation and FDA/ITC regulatory risk.

↑ Bull Case
  • 5.8% dividend yield backed by 60 consecutive years of dividend increases provides a durable income floor even if the stock stays range-bound.
  • 7.3% YoY adjusted EPS growth in Q1 2026 ($1.32 vs. $1.23 prior year) shows pricing power still more than offsetting cigarette volume declines.
  • 9.5% growth in total oral nicotine pouch industry volume for the six months ended March 2026 gives On! room to keep taking share from Zyn.
  • $5.56-$5.72 reaffirmed 2026 adjusted EPS guidance implies 2.5%-5.5% growth even with NJOY ACE excluded from the outlook entirely.
  • 15.25x current P/E sits below Altria's historical average and staples peers, leaving room for a re-rating if new CEO Sal Mancuso executes cleanly.
↓ Bear Case
  • 10% decline in domestic cigarette shipments in 2025 (to 61.8 million sticks) shows the core franchise's volume erosion is accelerating, not stabilizing.
  • 0 NJOY ACE units sold in 2026 after the U.S. ITC banned the device over Juul patent infringement, removing the flagship smoke-free growth catalyst.
  • 8.5% adjusted decline in oral tobacco shipment volume in Q1 2026 signals On! is losing share to Zyn even as the overall pouch category grows.
  • 101% dividend payout ratio in 2025 leaves minimal cushion, capping future dividend growth if cigarette declines outpace pricing offsets.
Catalyst: A revamped e-vapor product clears ITC/FDA hurdles and returns NJOY (or a successor) to market, On! nicotine pouch share stabilizes or grows against Zyn for two consecutive quarters, and domestic cigarette volume decline moderates to mid-single digits with pricing continuing to offset it.
Stop / exit: Domestic cigarette shipment declines accelerate into the low-double-digits or worse, the dividend payout ratio pushes further above 100% forcing a freeze or cut, or an adverse litigation ruling/new FDA menthol-flavor ban materially impairs volumes or cash flow.
The model points to a strong buy and the DCF math backs it — there is real margin of safety here, which is rare at this stage of the cycle. What I watch on this name is earnings consistency — specifically whether delivery against consensus is stable or deteriorating. That is usually where the rating gets confirmed or challenged before the price reflects it. The setup that would make me more positive is a quarter that confirms the operating leverage story. The setup that would make me cautious is any signal that consensus estimates are getting ahead of fundamentals.
— Anton Ladnyi, CFA
MO Earnings History — EPS Surprise Rate 2026
QuarterEPS Est.EPS ActualSurprise
Q1 2026$1.25$1.32+5.9%
Q4 2025$1.32$1.30-1.3%
Q3 2025$1.45$1.45+0.1%
Q2 2025$1.38$1.44+4.0%
$0.00$0.50$1.00$1.50$2.00 +4.0%+0.1%-1.3%+5.9% Q2'25Q3'25Q4'25Q1'26 BEAT RATE3/4 ESTIMATEBEATMISS EPS ACTUAL vs ESTIMATE · MO
MO Forward EPS Consensus Estimates 2026
QuarterEPS Est.YoY EPSAnalysts
Q2 2026$1.50+4.2%11
Q3 2026$1.50+3.7%11
Q4 2026~$1.36+4.6%13
Q1 2027~$1.47+11.4%13
~ Estimated from annual consensus — not a direct analyst survey
$0.00$0.60$1.20$1.80 +4%+4%+5%+11% Q2 2026Q3 2026Q4 2026Q1 2027 ESTIMATE TRENDCONTRACTING CONSENSUS EPSANALYST RANGEBased on 13 analyst estimates EPS FORWARD ESTIMATES · MO
MO Peer Valuation Comparison 2026
TickerP/E (TTM)Fwd P/EBetaCVaR-95Net Margin
MO14.9x12.2x0.49-13.6%39.5%
PM25.5x19.9x0.41-11.6%26.7%
KO26.0x23.7x0.35-5.7%27.8%
PG21.5x20.8x0.38-12.0%19.2%
PEP21.6x15.2x0.37-9.6%9.1%
Hover each scenario for detail · current price $71.59
BEAR$61BASE$76BULL$90 $72 DCF SCENARIO RANGE · MO
Bear Case
$61
-14.8%
Fwd P/E: 10.5x
-2% revenue CAGR · 11x exit multiple
Base Case
$76
+6.2%
Fwd P/E: 13.0x
3% revenue CAGR · 13.5x exit multiple
Bull Case
$90
+25.7%
Fwd P/E: 15.4x
6% revenue CAGR · 15x exit multiple
Pairwise Correlation Matrix — MO vs PM vs KO vs PEP vs PG 5×5 pairwise correlation matrix showing co-movement between MO, PM, KO, PEP, PG over a trailing 12-month window. MO PM KO PEP PG MO PM KO PEP PG 1.00 0.49 0.39 0.36 0.26 0.49 1.00 0.35 0.18 0.29 0.39 0.35 1.00 0.54 0.56 0.36 0.18 0.54 1.00 0.48 0.26 0.29 0.56 0.48 1.00
0 of 10 peer pairs correlated above 0.60 — diversification benefit within this cluster is structurally limited.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.

Is MO a buy, hold, or sell?

MO carries a valuation grade of Strong Buy. At a trailing P/E of 14.9, the stock trades at a 38% discount to the Consumer Defensive sector median of 24.0x. Our discounted cash flow model produces an intrinsic range of $75–$111 — implying a +29% margin of safety at the current price of $71.59. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.

With a 9% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 5.9% earnings surprise. Analyst estimate revisions are trending upward.

What are MO's key risk factors?

With a beta of 0.49, MO exhibits a low-volatility risk profile relative to the broad market. The 95th-percentile CVaR of -13.6% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.4% of total portfolio loss in the worst 5% of months. Net margins of 39.5% are significantly above the Consumer Defensive sector average of 12%, reflecting durable pricing power.

At 0.39, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 35.1% exceeds realized volatility of 24.8% by 10 points, suggesting options are pricing in elevated risk. Insiders have been net sellers to the tune of $1.6M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 3.1% of float, suggesting limited bearish conviction.

How does MO fit in a diversified portfolio?

At typical HENRY portfolio weights — 10–20% of the equity allocation — MO carries a beta of 0.49, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.

Among closely correlated names, MO shows the strongest co-movement with PM (0.49), KO (0.39), PEP (0.36). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.

True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The MO analysis here is a single node in that larger structure.

Is MO a buy or sell in 2026?

Altria Group Inc. (MO) carries a Strong Buy quantitative rating from A.L. Capital Advisory, derived from Discounted Cash Flow intrinsic value analysis, five-factor model scoring (Value, Quality, Momentum, Volatility, Size), and CVaR tail risk measurement. At $71.59, the DCF midpoint margin of safety is +29% (intrinsic value range: $75 bear – $111 bull). Composite factor score: 3.9/5. Strongest factor: Volatility (5.0/5). Weakest factor: Quality (3.0/5). Trailing P/E: 14.9x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Portfolio Construction Framework →

What is the average analyst target price for MO?

Wall Street consensus target for MO: $70.64 (-1.3% downside from the current price of $71.59). The analyst target range spans $59.00 (most bearish) to $82.00 (most bullish). Consensus recommendation: Hold. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory’s quantitative Strong Buy rating is produced independently — from DCF intrinsic value, five-factor model scores, and CVaR tail risk — and does not mechanically track Street consensus. When the two diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Monte Carlo Simulation Framework →

How does MO score on Value, Quality, Momentum, Volatility, and Size?

MO five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 4.5/5 (strong) — measures current price versus DCF intrinsic range and trailing earnings multiples; Quality 3.0/5 (neutral) — captures profitability metrics including return on equity, net margin and net margin (39.5%); Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 5.0/5 (strong) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.0/5 (above average) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.9/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Black-Litterman Model →

What is MO's tail risk and CVaR?

The 95th-percentile Conditional Value at Risk (CVaR) for MO on a one-month horizon is -13.6%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 0.49 indicates below-market volatility. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →

What is MO's intrinsic value and DCF price target?

A.L. Capital Advisory's DCF model produces an intrinsic value range of $75 (bear case) to $111 (bull case) for Altria Group Inc. (MO). At $71.59, the midpoint margin of safety is +29% (positive = discount to intrinsic mid; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and WACC. Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

What would trigger a rating upgrade or downgrade for MO?

Upgrade trigger: Upgrade to Strong Buy on evidence of accelerating earnings surprise magnitude combined with improvement in the Value factor score — specifically if the current 14.9x P/E is supported by an upward revision to DCF terminal growth assumptions. Downgrade trigger: a sustained reversal in the Quality and Momentum factor scores for two or more consecutive quarters. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Investment Policy Statement Framework →

Does MO consistently beat earnings estimates?

MO has beaten consensus EPS estimates in 9% of tracked quarterly periods — indicating inconsistent delivery. The most recent reported quarter beat consensus by 5.9%. Below-average earnings consistency is a primary headwind to the rating and a key watch item in the quantitative model. Earnings surprise magnitude and direction are incorporated into the Momentum and Quality dimensions of the five-factor scoring model. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →

How does MO contribute to portfolio risk and diversification?

MO carries a beta of 0.49 (low-volatility / defensive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: PM (0.49), KO (0.39), PEP (0.36). Holding MO alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →

What quantitative methodology does A.L. Capital Advisory use to analyse MO?

A.L. Capital Advisory analyses Altria Group Inc. (MO) using a four-component quantitative framework grounded in CFA Institute standards. (1) DCF Valuation: projects free cash flows under bear and bull assumptions, discounts at WACC to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude are incorporated into the Momentum and Quality factor scores. The current Strong Buy rating for MO is the output of applying this complete framework to current data. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →  ·  CVaR & Tail-Risk Methodology →

Stress-Test This View Live

Run MO in Asset Lens

Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.

Launch Live Analysis →
Anton Ladnyi — Founder & Portfolio Architect, A.L. Capital Advisory, ex-Goldman Sachs, CFA
Anton Ladnyi, CFA
Founder & Portfolio Architect — A.L. Capital Advisory
Ex-Goldman Sachs Equity Research · Ex-J.P. Morgan Wealth Management · CFA Charterholder
Legal Disclaimer & Important Notices

This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-07-09 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Altria Group Inc.

CFA Portfolio Advisory — MO Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.